SRx Health Solutions, Inc. Cash Flow Statement
SRXH|14 years of annual SEC 10-K data (FY2012-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 14 fiscal years. All figures from audited SEC 10-K filings.
SRx Health Solutions, Inc. used $1M in operating cash flow in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$43.1M | -$22.8M | -$39.3M | $3.4M | -$59.3M | -$184.5M | -$6.0M | -$1.7M | -$933.8K | -$49.7K | -$51.2K | -$16.2K | -$16.2K | -$16.2K |
| Depreciation & Amortization | $4.4M | $1.7M | $1.7M | $1.7M | $1.7M | $171.0K | $14.0K | - | $2.2K | $2.2K | $4.2K | $4.2K | $4.2K | $4.2K |
| Operating Cash Flow | -$1.5M | $97.0K | -$20.6M | -$11.9M | -$7.5M | -$21.0M | -$6.9M | -$39.8K | -$180.6K | -$22.9K | -$22.6K | -$17.2K | -$17.7K | -$18.4K |
| Capital Expenditures | - | $18.0K | $198.0K | $353.0K | $151.0K | $110.0K | $31.0K | - | $250.0K | $0 | - | - | - | - |
| Free Cash Flow | - | $79.0K | -$20.8M | -$12.2M | -$7.7M | -$21.1M | -$6.9M | - | -$430.6K | -$22.9K | - | - | - | - |
| Share Buybacks | $137.0K | $206.0K | - | $1.6M | $0 | - | - | - | - | - | - | - | - | - |
| FCF Margin | - | 0.2% | -38.0% | -26.5% | -18.0% | -135.3% | -46.9% | - | -897089.6% | - | - | - | - | - |